{"disease":{"id":"ovarian-cancer-tnbc-sclc-other-solid-tumours","name":"ovarian cancer tnbc sclc other solid tumours"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02482311","title":"Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}